Ab. Abdelmageed et Gm. Ghoniem, POTENTIAL ROLE OF REL NUCLEAR FACTOR-KAPPA-B IN THE PATHOGENESIS OF INTERSTITIAL CYSTITIS/, The Journal of urology, 160(6), 1998, pp. 2000-2003
Purpose: Despite assertive investigation in the last 2 decades, inters
titial cystitis remains an unresolved problem in clinical urology, and
its etiology and the mechanisms involved in its pathogenesis are stil
l a matter of conjecture. Recently nuclear factor (NF)-kappa B has bee
n implicated in chronic inflammatory diseases, and is thought to be a
key regulator of genes involved in response to infection, inflammation
and stress. We document the presence, pattern and distribution of NF-
kappa B in bladder biopsies from patients with interstitial cystitis.
Materials and Methods: Bladder biopsies from 7 women clinically diagno
sed with interstitial cystitis according to National Institute for Dia
betes and Digestive and Kidney Diseases criteria and 5 women diagnosed
with urinary incontinence were used for immunohistochemical localizat
ion of p65, an NF-kappa B subunit. Results: Our immunohistochemical lo
calization experiments indicate that NF-KB was predominantly activated
in bladder urothelial cells and cells of the submucosal layer in biop
sies from patients with interstitial cystitis compared to controls. Wh
ile activation was evident by intense nuclear localization of NF-kappa
B in all interstitial cystitis specimens, diffuse and faint immunosta
ining was observed in control samples. The results also indicate that
activation of NF-kappa B correlated with disease occurrence. Conclusio
ns: The fact that NF-kappa B is capable of transactivating pro-inflamm
atory mediators, which in turn can amplify NF-kappa B activation by a
positive regulatory loop, suggests that inflammatory and/or immune res
ponses in interstitial cystitis can be exacerbated possibly by persist
ent activation of this nuclear factor. We believe that our study provi
des a novel basis for investigating the role of NF-kappa B activation
in the pathophysiology of interstitial cystitis and further opens a fr
ontier for the development of an innovative therapeutic approach to in
terstitial cystitis.